Device shows promise for early detection of Alzheimer's

07/16/2014 | MedGadget.com

A device being commercialized by NeuroVision Imaging has been shown in a 40-patient study to have the ability to accurately detect Alzheimer's disease. Designed to identify beta-amyloid plaque buildup in the retina, the device eliminates the need to collect samples from the nervous system and could be used to detect Alzheimer's as early as two decades prior to a clinical diagnosis, according to researchers.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD